Research
Ketamine Demonstrates Rapid Antidepressant Effects Compared to Electroconvulsive Therapy in Major Depression Study
A groundbreaking study, published in the journal Psychiatry Research, has revealed that repeated doses of ketamine can have rapid antidepressant effects in hospitalized patients with major depressive disorder (MDD), offering a faster alternative to electroconvulsive therapy (ECT). The study involved a blind, randomized trial with 18 MDD patients, who were divided into two groups receiving either ketamine or ECT. Assessments using the Beck Depression Inventory and Hamilton Depression Rating Scale showed significant improvement in depressive symptoms within 24 hours of the first ketamine dose, an effect that persisted throughout the study. This research highlights ketamine's potential as a rapid and effective treatment for MDD, challenging traditional approaches like ECT.
Studies & Research
Ketamine in Major Depressive and Bipolar Disorder: A Meta-Analysis Review
Ketamine's Immediate and Extended Impact on Suicidality: A Medical Inpatient Study
Ketamine's Role in Reducing Alcohol Consumption: Targeting Maladaptive Reward Memories
Exploring Ketamine's Impact on Anxious Depression: MRI Insights into Brain Activity and Antidepressant Effects
Ketamine as a Dual Treatment for Depression and Alcohol Dependence: A Groundbreaking Study
Ketamine's Potential in Rapidly Reducing Suicidal Ideation: A Comparative Study
Late-Life Depression: Determining Optimal Ketamine Doses
Disclaimers
Financing Disclaimer: We offer two financing options for the Uplift Momentum Protocol™ (medical procedure): $325/month for 12 months, with a total cost of $3,900, no down payment, 0% APR, or $1,000 down payment and $237/month for 12 months, with a total cost of $3,844, 0% APR. Approval for both plans is based on internal criteria, including bank account history and a soft credit pull. Payments may be auto-withdrawn monthly. Both plans are subject to a $25 late fee for missed payments and other terms. Cancellation within 3 days of agreement is allowed. Governed by California law and AAA arbitration rules
Individuals showcased on KetamineUplift.com are actors, the content is not reflective of their thoughts, views, or perspectives.
Questions?
(310) 280-4440
care@ketamineuplift.com
4640 Admiralty Way
Suite 718A
Marina del Rey, CA 90292
© 2024 Ketamine Uplift | Terms & Conditions | Privacy Policy | HIPAA Policy
Research
Ketamine Demonstrates Rapid Antidepressant Effects Compared to Electroconvulsive Therapy in Major Depression Study
A groundbreaking study, published in the journal Psychiatry Research, has revealed that repeated doses of ketamine can have rapid antidepressant effects in hospitalized patients with major depressive disorder (MDD), offering a faster alternative to electroconvulsive therapy (ECT). The study involved a blind, randomized trial with 18 MDD patients, who were divided into two groups receiving either ketamine or ECT. Assessments using the Beck Depression Inventory and Hamilton Depression Rating Scale showed significant improvement in depressive symptoms within 24 hours of the first ketamine dose, an effect that persisted throughout the study. This research highlights ketamine's potential as a rapid and effective treatment for MDD, challenging traditional approaches like ECT.
Studies & Research
Ketamine in Major Depressive and Bipolar Disorder: A Meta-Analysis Review
Ketamine's Immediate and Extended Impact on Suicidality: A Medical Inpatient Study
Ketamine's Role in Reducing Alcohol Consumption: Targeting Maladaptive Reward Memories
Exploring Ketamine's Impact on Anxious Depression: MRI Insights into Brain Activity and Antidepressant Effects
Ketamine as a Dual Treatment for Depression and Alcohol Dependence: A Groundbreaking Study
Ketamine's Potential in Rapidly Reducing Suicidal Ideation: A Comparative Study
Late-Life Depression: Determining Optimal Ketamine Doses
Disclaimers
Financing Disclaimer: We offer two financing options for the Uplift Momentum Protocol™ (medical procedure): $325/month for 12 months, with a total cost of $3,900, no down payment, 0% APR, or $1,000 down payment and $237/month for 12 months, with a total cost of $3,844, 0% APR. Approval for both plans is based on internal criteria, including bank account history and a soft credit pull. Payments may be auto-withdrawn monthly. Both plans are subject to a $25 late fee for missed payments and other terms. Cancellation within 3 days of agreement is allowed. Governed by California law and AAA arbitration rules
Individuals showcased on KetamineUplift.com are actors, the content is not reflective of their thoughts, views, or perspectives.
Questions?
(310) 280-4440
care@ketamineuplift.com
4640 Admiralty Way
Suite 718A
Marina del Rey, CA 90292
© 2024 Ketamine Uplift | Terms & Conditions | Privacy Policy | HIPAA Policy